Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GSK 4023393A

X
Drug Profile

GSK 4023393A

Alternative Names: GSK-4023393; GSK-4023393A; MenABCWY-2Gen vaccine

Latest Information Update: 27 Jul 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlaxoSmithKline
  • Developer GSK
  • Class Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Meningococcal infections

Most Recent Events

  • 15 Feb 2022 Phase-II clinical trials in Meningococcal infections (In adolescents, In children, Prevention, In adults) in Belgium, Finland, Australia and USA (IM) (NCT04886154;GSK pipeline, February 2022)
  • 16 Nov 2021 Phase-II clinical trials in Meningococcal infections (In infants, Prevention) in United Kingdom, Spain, Poland, Germany, Finland (IM) (NCT05082285 ; EudraCT2021-001367-24)
  • 18 Oct 2021 GlaxoSmithKline plans a phase II trial in Meningococcal infections (Prevention, In Infants) (IM) (NCT05082285)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top